 Inovio Pharmaceuticals Inc.s INO, 5.06 stock tumbled 21.7 in premarket trading on Wednesday, the day after the company said it will discontinue its work on a COVID-19 vaccine and will instead focus only on developing a booster. Inovio also said it has replaced CEO Joseph Kim. 